Tower Research Capital »

Cerevel Therapeutics Hldng I shares owned by Tower Research Capital

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.4M 33k 40.89
2024-03-31 $31k 728 42.27
2023-09-30 $31k 1.4k 21.83
2023-06-30 $136k 4.3k 31.79
2023-03-31 $65k 2.7k 24.31
2022-12-31 $132k 3.7k 35.29
2022-09-30 $97k 4.6k 20.83
2022-06-30 $203k 6.1k 33.33
2022-03-31 $192k 5.5k 34.95
2021-12-31 $216k 5.8k 37.04
2021-09-30 $364k 12k 30.08
2021-06-30 $40k 1.6k 25.74
2021-03-31 $8.0k 609 13.14
2020-12-31 $2.0k 100 20.00